Qinghua Zhou - Concepedia

Author

Qinghua Zhou

Also Known As

Hai‐Yan Tu, Q Zhou, Q. H. Zhou, Q. Zhou, Q.H. Zhou, Qing-Hua Zhou, Qing-hua ZHOU, Qing-hua Zhou, QingHua Zhou, Qinghua ZHOU

383

Publications

5.8K

Citations

H-Index

101

Concepts

All Affiliations

Sichuan University Tianjin Medical University General Hospital Chinese Academy of Medical Sciences & Peking Union Medical College West China Hospital of Sichuan University Sichuan Cancer Hospital

About

Qinghua Zhou is an author at Sichuan University specializing in medicine, lung cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	22	2K
2	Engineering	3	3	126
3	Health Sciences	3	3	965
4	Natural Sciences	1	1	18
5	Public Health	1	1	17

Qinghua Zhou

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
Comparisons between the National Comprehensive Cancer Network (NCCN) non-small-cell lung cancer (NSCLC) Clinical Practice Guidelines (Chinese version), the NCCN original edition, and the European Society for Medical Oncology NSCLC Guidelines in 2009 Yan Xu, Hongyu Liu, Jun Chen, Thoracic Cancer Chinese VersionAdvanced Lung DiseaseMedicineCancer ManagementClinical Practice Guidelines	2010	890
Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer Yan Xu, Zheng Xiang, Mohammed Alnaggar, Cellular and Molecular Immunology	2020	232
Influence of Chemotherapy on <i>EGFR</i> Mutation Status Among Patients With Non–Small-Cell Lung Cancer Hua Bai, Zhijie Wang, Ke‐Neng Chen, Journal of Clinical Oncology	2012	207
MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN Boning Liu, Xiang Wu, Bin Liu, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease Mir-26a EnhancesOncologyAkt PathwayMedicineMicrorna Detection	2012	183
Promoting effect of neutrophils on lung tumorigenesis is mediated by CXCR2 and neutrophil elastase Lei Gong, Amber M. Cumpian, Mauricio S. Caetano, Molecular Cancer	2013	169
[Results of randomized, multicenter, double-blind phase III trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients]. Jinwan Wang, Yan Sun, Qitao Yu, PubMed	2005	147
Potential application of non-small cell lung cancer-associated autoantibodies to early cancer diagnosis Yibing Yao, Yu Fan, Jun Wu, Biochemical and Biophysical Research Communications Early Cancer DiagnosisAutoimmune DiseaseAutoantibody ProductionMultiple Pulmonary NoduleImmunology	2012	144
EXPRESSION OF CONCERN: Functional p53 determines docetaxel sensitivity in prostate cancer cells Chengfei Liu, Yezi Zhu, Wei Lou, The Prostate	2012	122
MiR-132 Suppresses the Migration and Invasion of Lung Cancer Cells via Targeting the EMT Regulator ZEB2 Jiacong You, Yang Li, Nianzhen Fang, PLoS ONE	2014	120
Clinical Significance of EML4-ALK Fusion Gene and Association with EGFR and KRAS Gene Mutations in 208 Chinese Patients with Non-Small Cell Lung Cancer Ying Li, Tong Yang, Sen Wei, PLoS ONE Eml4-alk Fusion GeneTumor MicroenvironmentEml4-alk TranslocationKras Gene MutationsMedicine	2013	116

Page 1